pharmaceutical grade bpc-157 BPC-157 Analytical Reference Standard |

If a target dose is 250 micrograms, draw 0.1 mL (10 units on a U-100 insulin syringe)

Studies demonstrate healing effects on: Stomach ulcers Intestinal damage Inflammatory bowel conditions Fistulas Rats with induced inflammatory bowel disease showed significant improvement with BPC-157 treatment

BPC-157 or Body Protection Compound-157 is a pentadecapeptide consisting of 15 amino acids

Lower doses can be used to study minor injuries

What's changed in 2026 is that the regulatory environment requires more specificity from providers about sourcing and compliance, and gives patients better grounds for distinguishing between clinics that are tracking the regulatory picture and those that aren't

Additionally, Tirzepatide has been found to lower fasting blood glucose levels & increase weight loss in participants who were overweight or obese at the start of clinical trials